Lilly Asia Ventures

Venture capital · Hong Kong, Hong Kong

Founded in 2008, Lilly Asia Ventures is a corporate venture capital arm of Eli Lilly headquartered in Hongkong. 8 portfolio companies and 1 fund are on record.

AUM
$5.6B
Portfolio companies
8
Recorded deals
307
14 in last 12M
Last investment
—

Lilly Asia Ventures's book

8 companies · priced for members
CompanyValuationRole
InSilico Medicine Cayman (HKG: 03696)▮▮
Caidya▮▮
Avenzo Therapeutics▮▮
+ 5 more companies · all 8, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Lilly Asia Ventures portfolio at a glance

8 portfolio companies are on record for Lilly Asia Ventures, including InSilico Medicine Cayman (HKG: 03696), Caidya and Avenzo Therapeutics.

6 of the 8 carry a recorded valuation.

Free account
See more of the book
  • ·The top 10 names in the book — of 8 recorded positions
  • ·Watchlist + alerts for Lilly Asia Ventures's activity
Create free account

Membership and data by Private Market View

No card required